tryptophan has been researched along with Cortical Lewy Body Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, TJ; Collins, C; Dalrymple-Alford, JC; Mace, JL; Porter, RJ | 1 |
| Driguès, N; Sagi, Y; Youdim, MB | 1 |
1 trial(s) available for tryptophan and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Acute tryptophan depletion and Lewy body dementias.
Topics: Aged; Cognition Disorders; Cross-Over Studies; Deficiency Diseases; Dementia; Double-Blind Method; Female; Humans; Lewy Body Disease; Male; Memory, Short-Term; Neuropsychological Tests; New Zealand; Serotonin; Tryptophan | 2016 |
1 other study(ies) available for tryptophan and Cortical Lewy Body Disease
| Article | Year |
|---|---|
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocampus; Hyperkinesis; Indans; Levodopa; Lewy Body Disease; Male; Monoamine Oxidase Inhibitors; Motor Activity; Muscarinic Antagonists; Norepinephrine; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Serotonin; Time Factors; Tranylcypromine; Tryptophan | 2005 |